Corbus Pharmaceuticals Holdings, Inc.

By person

22 insiders · 140 transactions

1.9×

Yuval Cohen holds only 1.9 times base salary in stock. $1.23M of shares against $646.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Yuval Cohen last reported holding, valued at $7.84, the price Common Stock, par value $0.0001 per share was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Cormorant Asset Management, LP entity

10% owner

$53.69M (31)

$344.01K (1)

+$53.35M

2,344,971

12.12%

$18.39M

+430.1%

Cohen Yuval

Chief Executive Officer

$122.23K (15)

$3.76M (13) scheduled

−$3.64M

157,316

0.8134%

$1.23M

—

Moran Sean F.

Chief Financial Officer

$144.20K (12)

$1.54M (11) scheduled

−$1.40M

84,694

0.4379%

$664.13K

—

Hochman David P

Director

$269.18K (7)

—

+$269.18K

814,400

4.21%

$6.39M

+5.9%

White Barbara

Chief Medical Officer

$254.36K (12)

—

+$254.36K

206,217

1.07%

$1.62M

+28.0%

Saxena Nishant C

Chief Business Officer

$126.25K (3)

—

+$126.25K

77,900

0.4028%

$610.85K

+2,126%

Smethurst Dominic

Chief Medical Officer

—

$120.51K (3)

−$120.51K

89,790

0.4642%

$704.09K

—

Discordia Robert Paul

Chief Operating Officer

$109.51K (3)

—

+$109.51K

35,490

0.1835%

$278.29K

+134.3%

Panayiotopoulos Paris

Director

$100.39K (1)

—

+$100.39K

14,285

0.0739%

$112.02K

—

Millian Craig Stuart

Chief Operating Officer

$76.55K (8)

—

+$76.55K

27,000

0.1396%

$211.72K

—

Jenkins John Kenneth

Director

$6.98K (1)

$58.45K (2) scheduled

−$51.47K

3,833

0.0198%

$30.06K

—

Altmeyer Anne

Director

—

$50.91K (3) scheduled

−$50.91K

7,579

0.0392%

$59.43K

—

CATLIN AVERY W

Director

$45.84K (2)

—

+$45.84K

4,350

0.0225%

$34.11K

—

Hodgson Ian

Chief Operating Officer

—

$25.79K (2)

−$25.79K

51,080

0.2641%

$400.54K

+96.6%

Kung Winston

Director

—

$16.03K (1) scheduled

−$16.03K

12,140

0.0628%

$95.20K

—

Ben Yong

Director

—

$15.68K (1) scheduled

−$15.68K

9,383

0.0485%

$73.58K

—

HOLMER ALAN F

Director

$10.61K (2)

—

+$10.61K

10,629

0.0550%

$83.35K

—

Tepper Mark

President and CSO

—

2,110,400

10.91%

$16.55M

+0.5%

Nicacio Leonardo Viana

Chief Medical Officer

—

58,333

0.3016%

$457.42K

—

Jacques Rachelle Suzanne

Director

—

11,383

0.0589%

$89.26K

—

Pfeiffenberger Brent

Director

—

7,500

0.0388%

$58.81K

—

Salzmann Peter

Director

—

2,783

0.0144%

$21.82K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Ben Yong

14 Sep 2026

Director

Sold on a plan

2,000

$7.84

$15.68K

Moran Sean F.

7 Aug 2026

Chief Financial Officer

Sold on a plan

12,000

$10.08

$120.97K

Cohen Yuval

7 Aug 2026

Chief Executive Officer

Sold on a plan

17,000

$10.08

$171.40K

Jenkins John Kenneth

10 Jun 2026

Director

Sold on a plan

4,800

$7.91

$37.99K

Altmeyer Anne

10 Jun 2026

Director

Sold on a plan

2,412

$7.91

$19.09K

Kung Winston

10 Jun 2026

Director

Sold on a plan

2,026

$7.91

$16.03K

Cohen Yuval

13 Feb 2026

Chief Executive Officer

Sold on a plan

13,871

$7.78

$107.95K

Moran Sean F.

13 Feb 2026

Chief Financial Officer

Sold on a plan

4,701

$7.78

$36.59K

Altmeyer Anne

30 May 2025

Director

Sold on a plan

1,392

$7.25

$10.10K

Jenkins John Kenneth

30 May 2025

Director

Sold on a plan

2,783

$7.35

$20.47K

Cohen Yuval

14 Feb 2025

Chief Executive Officer

Sold on a plan

7,134

$8.76

$62.46K

Moran Sean F.

14 Feb 2025

Chief Financial Officer

Sold on a plan

2,792

$8.76

$24.45K

Show all 140 transactions →

Corbus Pharmaceuticals Holdings, Inc.

By person

Individual transactions

What was left out